US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

  1. November 13, 2025

    Objecting Claimants Have Their Say On Purdue Ch. 11 Plan

    A New York bankruptcy judge heard statements from more than a dozen opioid personal injury claimants objecting to the Chapter 11 plan of OxyContin maker Purdue Pharma Thursday as the pro se objectors shared concerns about their recoveries, the lack of criminal prosecution of the company's owners and faults in the system that allowed the opioid crisis to occur in the first place.

  2. November 12, 2025

    Purdue Kicks Off Ch. 11 Confirmation With Plan Overview

    Bankrupt OxyContin maker Purdue Pharma began its Chapter 11 confirmation trial Wednesday with an overview of its latest plan and the myriad settlements that underpin the proposal, including a $6.5 billion commitment from the company's owners.

  3. November 07, 2025

    Purdue Expects Smooth Confirmation Of New $7.5B Plan

    Bankrupt drugmaker Purdue Pharma will begin a confirmation trial for its latest Chapter 11 plan Wednesday in a vastly different position than the last time it came to court seeking similar relief in 2021, when a New York judge approved a plan — over the objections of key parties — that was later struck down by the U.S. Supreme Court.

  4. November 07, 2025

    What's Happening In Bankruptcy Court This Coming Week

    It's a confirmation-seeking bonanza in the coming week as the Archdiocese of New Orleans will come to court for a pretrial conference related to its bankruptcy plan, Purdue will seek confirmation of its Chapter 11 plan, and Yellow Corp. will make its own bid for plan approval.

  5. October 27, 2025

    Purdue Defends Ch. 11 Plan, Heritage Coal's Gets OK'd

    Pharmaceutical titan Purdue Pharma hailed support for its proposed bankruptcy plan and fought an objection from the city of Baltimore, Heritage Coal got its Chapter 11 plan approved, and a Texas bankruptcy judge granted LifeScan's conditional approval. This is the week in bankruptcy.

  6. October 22, 2025

    Purdue Fights Baltimore Objection Ahead Of Ch. 11 Plan Trial

    Purdue Pharma LP told a New York bankruptcy judge on Wednesday it is concerned a recent objection to its Chapter 11 plan brought by the city of Baltimore could disrupt its case just weeks before the drugmaker is set to begin trial on a deal that creditors overwhelmingly support.

  7. October 21, 2025

    Purdue Touts Wide Support For Latest Ch. 11 Plan

    Pharmaceutical titan Purdue Pharma heralded Tuesday that its newest Chapter 11 plan has almost total support from voting creditors, saying the proposal could pave the way to creditors receiving more than $7 billion, after its well-publicized role in the opioid epidemic pushed the company into bankruptcy and the U.S. Supreme Court rejected its original plan.

  8. October 17, 2025

    What's Happening In Bankruptcy Court This Coming Week

    Village Roadshow's third proposed sale will go before a judge. A bankruptcy court will consider confirming Heritage Coal's liquidation plan. And a CVS Health subsidiary will seek final approval of its bankruptcy financing.

  9. September 22, 2025

    Rite Aid Can Seek Plan Votes, Purdue CEO Bonus Approved

    A New Jersey bankruptcy judge gave Rite Aid the go-ahead to solicit Chapter 11 plan votes. A New York bankruptcy judge gave permission for Purdue Pharma to offer its chief executive a nearly $3 million incentive package. And a Delaware judge approved fiber network developer Tilson Technology Management Inc.'s asset sale to ITG Communications LLC.

  10. September 17, 2025

    Purdue Can Pay CEO Ch. 11 Bonus After Trimming Comp

    A New York bankruptcy judge Wednesday approved a nearly $3 million incentive program for Purdue Pharma's chief executive after he agreed to reduce his total compensation by $500,000.